DNA Ginkgo Bioworks Holdings, Inc.

DNA Ginkgo Bioworks Holdings, Inc.

Healthcare · Biotechnology

Market read

Scan convergence 1 scan as of 2026-08-14 1 bear converging

POC $9.19 · VWAP $9.79 · -29.3% vs 12m avg buyer

downtrend vol: normalgaps: overnight-shiftchurn: quiet as of

Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)

Coverage

2 watchlists

Watchlists @biotech-capital-cycle@biotech-scan

DNA Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist DNA belongs to, members best 30-day change first — DNA highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

@biotech-capital-cycle
View watchlist →
ABCL+73.1% -1.6%1d +19.9%7d TXG+32.6% +3.4%1d -1.1%7d TWST+32.6% +4.9%1d -0.3%7d CRL+27.8% +2.4%1d +3.4%7d ALMR+23.8% -3.1%1d +14.8%7d AVTR+21.9% -1.2%1d -1.6%7d IQV+17.0% +1.9%1d -0.2%7d GENB+15.7% +0.3%1d +6.6%7d CERT+15.4% 0.0%1d -0.9%7d RGEN+14.8% +1.3%1d +3.6%7d SDGR+13.6% -1.1%1d -7.4%7d A+12.9% -0.1%1d -0.2%7d ABSI+11.3% +0.7%1d +2.5%7d MEDP+11.0% +3.2%1d -0.9%7d WAT+10.5% -1.1%1d -1.0%7d TMO+10.0% -0.5%1d -2.3%7d MTD+8.2% -0.1%1d -0.6%7d RXRX+5.8% -1.6%1d -5.2%7d RVTY+5.5% -0.6%1d +0.1%7d ILMN+3.5% +1.2%1d +0.7%7d XBI+3.4% +1.4%1d +1.0%7d FTRE+1.9% +4.0%1d -4.6%7d SLP+0.7% +0.1%1d +0.1%7d ICLR-0.3% +3.9%1d +2.0%7d DHR-0.6% +0.1%1d -3.2%7d BRKR-1.0% -0.1%1d +2.4%7d TEM-1.6% -0.9%1d -6.2%7d SEER-6.5% -2.4%1d -5.5%7d VKTX-9.3% +1.3%1d -2.2%7d QSI-9.8% 0.0%1d -6.3%7d DNA-12.5% +1.9%1d -9.4%7d AGIO-15.1% +0.2%1d +3.1%7d PACB-16.0% +5.2%1d +4.3%7d LAB-23.6% -4.2%1d -11.5%7d QTRX-24.6% +12.7%1d +21.2%7d CDXS-29.0% +1.9%1d +7.4%7d NAUT-49.4% -1.1%1d +2.3%7d
@biotech-scan
View watchlist →
REGN+19.1% +0.3%1d -0.3%7d IQV+17.0% +1.9%1d -0.2%7d DXCM+15.8% -1.1%1d +1.3%7d AMGN+14.5% +1.0%1d +0.5%7d CRSP+13.6% +1.4%1d +1.6%7d ISRG+13.0% -1.1%1d -0.8%7d A+12.9% -0.1%1d -0.2%7d PTGX+12.6% +2.3%1d +5.9%7d BMRN+11.8% -1.1%1d -3.3%7d TMO+10.0% -0.5%1d -2.3%7d MDT+8.9% -0.7%1d +1.3%7d IMVT+8.6% +4.5%1d +9.8%7d LABU+8.2% +3.9%1d +2.5%7d IONS+7.8% +2.4%1d +3.0%7d NKTR+6.5% -0.5%1d -2.9%7d IBB+6.4% +1.9%1d +0.9%7d NTLA+6.2% +1.5%1d +0.6%7d VRTX+6.2% +1.9%1d -1.6%7d RXRX+5.8% -1.6%1d -5.2%7d SRPT+5.6% +0.4%1d +5.9%7d INCY+5.3% +2.8%1d +1.6%7d IBBQ+5.2% +1.4%1d +0.5%7d KYMR+4.9% +3.4%1d +11.8%7d MRNA+4.3% +1.8%1d +7.7%7d ILMN+3.5% +1.2%1d +0.7%7d GILD+3.5% +0.4%1d +4.4%7d XBI+3.4% +1.4%1d +1.0%7d BIIB+1.5% -0.3%1d +1.0%7d LLY+0.3% +0.3%1d -3.8%7d BNTX+0.1% -1.6%1d -1.3%7d DHR-0.6% +0.1%1d -3.2%7d BEAM-1.6% +1.3%1d -0.6%7d ABBV-1.6% +0.3%1d +1.0%7d COGT-3.1% -0.2%1d -8.7%7d EDIT-4.7% +0.7%1d +0.7%7d LEGN-7.2% +1.4%1d -0.1%7d RARE-10.8% -1.4%1d -2.6%7d NVO-10.8% -2.2%1d -6.0%7d DNA-12.5% +1.9%1d -9.4%7d ALNY-16.0% -1.8%1d +3.5%7d

Next earnings DNA reports in 79 days Nov 5

Last report May 7

Reported the quarter ending 2026-03-31: revenue $19M, net income $-83M (SEC filing). Across the print the stock moved -11.4% (close before → first close after).

full note →

Against street estimates

How DNA's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 10 quarters · newest report Aug 5 · projection Aug 17

Result
Aug 5 -0.70-0.73-4.7%Miss
May 7 -1.34-1.39-3.7%Miss
Feb 26 -1.11-0.77+30.5%Beat
Nov 6 '25 -1.24-1.45-16.9%Miss
Aug 7 '25 -1.57-1.10+29.8%Beat
May 6 '25 -1.77-1.68+5.1%Beat
Feb 25 '25 -1.30-1.21+6.7%Beat
Nov 12 '24 -3.32-1.08+67.5%Beat

News (last pull)

Headlines about DNA from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.

pulled 111 days ago · Apr 29

DNA research tape

23 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.

scan Biotech Scan — August 14, 2026 scan Biotech Scan — August 8, 2026 earnings DNA earnings — 2026-08-05 scan Biotech Scan — July 31, 2026 scan Biotech Scan — July 28, 2026
Types
Aug 14 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Aug 8 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Aug 5 Catalyst DNA earnings
DNA
Jul 31 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 28 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 25 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 17 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 11 Scan Biotech Scan
ABBVXBIIBBIBBQLABUMRNABIIBLLY +4 more
Jul 7 Scan Biotech Scan
ABBVXBIIBBIBBQLABUMRNABIIBLLY +4 more
Jun 26 Scan Biotech Scan
ABBVXBIIBBIBBQLABUMRNABIIBLLY +4 more
Jun 16 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
May 29 Scan Biotech Scan
AABBVALNYAMGNBEAMBIIBBMRNBNTX +4 more
May 7 Catalyst DNA earnings
DNA
Apr 28 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNBNTXCOGT +4 more
Apr 26 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNBNTXCOGT +4 more
Mar 26 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNBNTXCRSP +4 more
Mar 20 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNBNTXCRSP +4 more
Mar 13 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNBNTXCRSP +4 more
Mar 12 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNBNTXCRSP +4 more
Mar 11 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBLUEBMRNBNTX +4 more
Mar 10 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBLUEBMRNBNTX +4 more
Feb 5 Scan Biotech Scan
ALNYBEAMBIIBBMRNBNTXCRSPDNAEDIT +4 more
Feb 2 Scan Biotech Universe
ABBVALNYAMGNBEAMBIIBBMRNBNTXDHR +4 more